Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Molecular and Cellular Biology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Articles

Mechanistic Studies of the Mitotic Activation of Mos

Jianbo Yue, James E. Ferrell, Jr
Jianbo Yue
Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, California 94305-5174
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jyue@Stanford.edu
James E. Ferrell
Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, California 94305-5174
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/MCB.00273-06
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Mitotic activation of Mos. (A) Activation of recombinant GST-Flag-Mos by Δ90-cyclin B-treated Xenopus egg extracts. The top blot shows Mos activity as indicated by an in vitro kinase assay using recombinant GST-MEK1 as a substrate and phospho-MEK1 immunoblotting to detect the amount of MEK1 phosphorylation. The bottom blot shows that equal levels of GST-Flag-Mos protein were present in the two samples. The bar graph shows pooled data from four independent experiments, with data expressed as means ± standard deviations. (B) Electrophoretic mobility shift of recombinant GST-Flag-Mos incubated with Δ90-cyclin B-treated Xenopus egg extracts. Samples were immunoprecipitated with Flag antibody and immunoblotted with Mos antibody.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Mos phosphorylation sites. (A) GST-Flag-Mos was treated with Δ90-cyclin B-treated Xenopus egg extracts or interphase extracts and subjected to immunoprecipitation with Flag antibody, followed by Coomassie blue staining (top) or immunoblotting with Mos antibody (bottom). “ns” designates a nonspecific band that ran just above Mos. (B) Schematic depiction of the Mos domain structure and the mapped phosphorylation sites. We have highlighted the kinase domain, helix αC, the region of Mos important for interaction with CK2β (21), and the T loop, or activation loop.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Electrophoretic mobility shifts in Mos phosphorylation site mutants. Samples of wild-type GST-Flag-Mos (Mos-WT) and various Mos mutants were incubated with Δ90-cyclin B-treated Xenopus egg extracts or interphase extracts and were then immunoprecipitated with Flag antibody and immunoblotted with Mos antibody.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Effects of phosphorylation on Mos activity. (A) Effect of λ phosphatase treatment on Mos activity. GST-Flag-Mos was treated with Δ90-cyclin B-treated Xenopus egg extracts or interphase extracts and subjected to immunoprecipitation with Flag antibody. Samples were then treated with λ phosphatase (λ P'ase) or were mock phosphatase treated and were subjected to an in vitro kinase assay using recombinant GST-MEK1 as a substrate and phospho-MEK1 immunoblotting to detect the amount of MEK1 phosphorylation. The phospho-MEK1 and Mos blots are taken from one experiment. The bar graph shows data from three independent experiments expressed as means ± standard deviations. (B) Activities of various phosphorylation site mutants. Kinase assays and blot analyses were carried out as described for panel A. The bar graph shows data from three independent experiments expressed as means ± standard deviations. WT, wild type. (C) Reconstitution of the mitotic phosphorylation of p42 MAPK by adding Mos mutants back to Mos-depleted extracts. Extracts were depleted of Mos by two rounds of sequential immunodepletion. A nominal concentration of 30 nM wild-type GST-Flag-Mos and various Mos mutants was added back to the Mos-depleted extracts. The top panel shows a Mos blot of the extracts. The bottom panels show p42 MAPK blots and histone H1 kinase assay results for the Mos-depleted extracts and Mos-reconstituted extracts after incubation with or without Δ90-cyclin B. Other studies showed that concentrations of Mos-S3A and Mos-S105E as high as 120 nM still failed to restore mitotic phosphorylation of p42 MAPK, as judged by the electrophoretic mobility shift (data not shown). bkgd, background bard. (D) Activities of various multisite mutants. Kinase assays and blot analyses were carried out as described for panel A. The bar graph shows data from three independent experiments expressed as means ± standard deviations.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Regulated dissociation of CK2β from Mos. (A) Cyclin-dependent phosphorylation of p42 MAPK in CK2β-depleted extracts. Extracts were subjected to two rounds of immunodepletion with nonspecific immunoglobulin G or anti-CK2β. To one aliquot of the CK2β-depleted extract, we added back recombinant CK2β to restore normal levels of the protein. The resulting levels of CK2β were determined by immunoblotting (left). The mock-depleted, CK2β-depleted, and CK2β-depleted/restored extracts were then treated with or without Δ90-cyclin B and subjected to phospho-MAPK immunoblotting and histone H1 kinase assays (right). (B) Cyclin-dependent phosphorylation of p42 MAPK in CK2β-supplemented extracts. Extracts were treated with buffer or CK2β (1 μM) for 30 min and then were treated with Δ90-cyclin B. Samples were taken at various times and subjected to phospho-MAPK immunoblotting and histone H1 kinase assays. (C) Dissociation of CK2β from Mos in M phase. Recombinant GST-Flag-CK2β (20 nM) and either wild-type GST-Flag-Mos (Mos-WT) or one of two quadruple-phosphorylation-site Mos mutants (20 nM) were added to Xenopus egg extracts with or without Δ90-cyclin B. Lysates were immunoblotted with Flag antibody (left) or were subjected to immunoprecipitation with Mos antibody, followed by immunoblotting with Flag antibody (right). Note that different Mos mutants were pulled down with differing efficiencies (e.g., compare lanes 9 and 10 with lanes 11 and 12), but cyclin treatment had no effect on the efficiency of the Mos pulldown (lane 7 versus lane 8; lane 9 versus lane 10; lane 11 versus lane 12).

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Biological function of Mos phosphorylation site mutants. (A) Oocyte maturation. Oocytes were incubated with progesterone or buffer or were microinjected with one of the seven GST-Flag-Mos proteins as indicated. Maturation was scored as a function of time, using the appearance of a white dot at the animal pole of the oocyte as an indicator of maturation. (B) Spindle assembly checkpoint. CSF-arrested Xenopus egg extracts were subjected to two rounds of Mos immunodepletion or mock depletion. Sperm chromatin was added at a concentration of 15,000 per μl, and calcium (1 mM) was added in the absence and presence of nocodazole (10 ng/μl). Histone H1 kinase assays were monitored as functions of time. WT, wild type.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Phosphorylation of Mos at Ser 3 and Ser 105 during oocyte maturation and after egg activation. (A) Specificities of the pS3-Mos and pS105-Mos antibodies. Wild-type (WT) or mutant GST-Flag-Mos was treated with Δ90-cyclin B-treated Xenopus egg extracts or interphase extracts and subjected to immunoprecipitation with Flag antibody, followed by immunoblotting with pS3-Mos and pS105-Mos antibodies. (B) Mos accumulation and phosphorylation during oocyte maturation. Oocytes were treated with progesterone for various lengths of time. Lysates were subjected to immunoblotting with Mos, pS3-Mos, and pS105-Mos antibodies. The asterisks denote nonspecific protein bands in the Mos blots. p42 MAPK blots and H1 kinase (H1K) assay results are shown for comparison. (C) Mos degradation and phosphorylation after egg activation. Dejellied eggs were treated with calcium ionophore and blotted for Mos, pS3-Mos, and pS105-Mos. p42 MAPK blots and H1 kinase assay results are shown for comparison. (D) Schematic depiction of the changes in Mos phosphorylation and CK2β-association between interphase and M phase.

PreviousNext
Back to top
Download PDF
Citation Tools
Mechanistic Studies of the Mitotic Activation of Mos
Jianbo Yue, James E. Ferrell Jr
Molecular and Cellular Biology Jun 2006, 26 (14) 5300-5309; DOI: 10.1128/MCB.00273-06

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Molecular and Cellular Biology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mechanistic Studies of the Mitotic Activation of Mos
(Your Name) has forwarded a page to you from Molecular and Cellular Biology
(Your Name) thought you would be interested in this article in Molecular and Cellular Biology.
Share
Mechanistic Studies of the Mitotic Activation of Mos
Jianbo Yue, James E. Ferrell Jr
Molecular and Cellular Biology Jun 2006, 26 (14) 5300-5309; DOI: 10.1128/MCB.00273-06
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About MCB
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #MCBJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

Copyright © 2019 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0270-7306; Online ISSN: 1098-5549